Tetraphase Pharmaceuticals, Inc.
5.7800
-6.02%
5.7800
-6.02%
3.5710 9.9300
52 weeks
52 weeks

Mkt Cap 231.23M

Shares Out 40.01M

new Chat
Send me real-time posts from this site at my email

Tetraphase's antibiotic succeeds late-stage study, shares soar

(Reuters) - Tetraphase Pharmaceuticals Inc said its lead experimental antibiotic for serious bacterial infections met the main goal in a late-stage study, sending its shares surging nearly 23 percent in after-market trading on Tuesday.

The company said the antibiotic, eravacycline, was being studied in a pivotal 500 patient late-stage study...


More
Cancel
Followers
6